Genetic basis of macrolide resistance in Mycobacterium avium isolated from patients with disseminated disease.
Ontology highlight
ABSTRACT: Clarithromycin (CLM) and azithromycin (AZM) are important agents in the treatment of disseminated Mycobacterium avium complex disease; however, monotherapy with these macrolides often leads to clinically significant resistance. The underlying resistance mechanism was investigated by comparing 23S rRNA gene sequences in the domain V region of 10 CLM-susceptible strains included in this study. The only differences in the domain V sequences associated with CLM resistance were at position 2274 of the complete M. avium 23S rRNA gene (GenBank accession no. X74494). All the CLM-susceptible strains had an A residue at this site, whereas seven of the eight CLM-resistant strains had either a C, G, or T. Four of these seven CLM-resistant strains emerged during monotherapy with CLM and two emerged dur
SUBMITTER: Nash KA
PROVIDER: S-EPMC163001 | biostudies-literature | 1995 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA